Literature DB >> 8096493

Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.

O Marasco1, F Melina, E Mele, B Quaresima, A Zingone, E Focarelli, E Picciotti, M L Martelli, L Fotino, M F Vigna.   

Abstract

We analysed the allelic and genotypic frequencies of three restriction fragment length polymorphisms in the region of chromosome 11 encoding apolipoprotein AI and CIII genes in a free-living population from South Italy (Calabria). These markers are located at -2500 and -78 bp from the transcription start site of apolipoprotein AI gene (XmnI and MspI, respectively), and in the 3' untranslated region of apolipoprotein CIII gene (SstI). XmnI and SstI label rare alleles (X2 and S2 indicate the presence of the site), whereas the absence of the MspI site (because of a G to A transition) marks the rare allele, M2. Pairwise linkage disequilibrium analysis was determined. Two significant non-random associations were found: a positive disequilibrium between ApoA1/XmnI and ApoA1/MspI markers (P < 0.0001), and a negative disequilibrium between ApoA1/XmnI and ApoC3/SstI markers (P < 0.05). Statistical analysis showed a significant difference in the S2-M2 haplotype frequency between the group of subjects with serum cholesterol levels in the highest decile (P < 0.005) and the group with serum cholesterol levels below the highest decile. The allelic frequency for each locus showed no significant difference between the two groups for all other metabolic parameters, included total cholesterol serum levels. These haplotypes are a more precise measure of genetic variations in the apolipoprotein cluster and their use should allow the mapping of mutations responsible for high serum cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096493     DOI: 10.1007/bf00222719

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

1.  Extended haplotypes and linkage disequilibrium between 11 markers at the APOA1-C3-A4 gene cluster on chromosome 11.

Authors:  P Benlian; C Boileau; N Loux; D Pastier; J Masliah; M Coulon; M Nigou; A Ragab; J Guimard; J B Ruidavets
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

2.  Human gene mapping 10.5. Oxford Conference (1990). Update to the Tenth International Workshop on Human Gene Mapping.

Authors: 
Journal:  Cytogenet Cell Genet       Date:  1990

3.  Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population.

Authors:  A Rees; J Stocks; H Paul; Y Ohuchi; D Galton
Journal:  Hum Genet       Date:  1986-02       Impact factor: 4.132

4.  The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III.

Authors:  N A Elshourbagy; D W Walker; M S Boguski; J I Gordon; J M Taylor
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

5.  Experience with new DNA markers for the diagnosis of cystic fibrosis.

Authors:  A L Beaudet; J E Spence; M Montes; W E O'Brien; X Estivill; M Farrall; R Williamson
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

6.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

7.  DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups.

Authors:  H Paul; D Galton; J Stocks
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

8.  Apolipoprotein CIII polymorphism and coronary heart disease.

Authors:  W H Price; S W Morris; R Burgon; P M Donald; A H Kitchin
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

9.  DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis.

Authors:  S K Karathanasis; E Ferris; I A Haddad
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.

Authors:  M Jeenah; A Kessling; N Miller; S Humphries
Journal:  Mol Biol Med       Date:  1990-06
View more
  2 in total

1.  Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels.

Authors:  A Zingone; A Dominijanni; E Mele; O Marasco; F Melina; P Minchella; B Quaresima; M T Tiano; A Gnasso; A Pujia
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

2.  Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.

Authors:  L Rigoli; G Raimondo; A Di Benedetto; G Romano; A Porcellini; S Campo; F Corica; G Riccardi; G Squadrito; D Cucinotta
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.